Exact Sciences (Madison, Wisconsin) said it has submitted to the FDA the final module of its PMA application for Cologuard, the company's stool DNA (sDNA) colorectal cancer screening test. The final module, which is comprised of data from the company's DeeP-C clinical trial, completes the company's PMA application for the product.